Macquarie Group

Macquarie Group’s Lexicon Pharmaceuticals LXRX Stock Holding History

Macquarie Group’s Portfolio LXRX Stock Details LXRX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q1	–	Sell	-11,697	Closed	-$40K	–	2478
2020 Q4	$40K	Hold	11,697	–	–	﹤0.01%	2092
2020 Q3	$17K	Hold	11,697	–	–	﹤0.01%	2198
2020 Q2	$23K	Hold	11,697	–	–	﹤0.01%	2133
2020 Q1	$23K	Hold	11,697	–	–	﹤0.01%	1906
2019 Q4	$49K	Sell	11,697 -438,303	-97%	-$1.69M	﹤0.01%	1852
2019 Q3	$1.35M	Hold	450,000	–	–	﹤0.01%	1134
2019 Q2	$2.83M	Hold	450,000	–	–	﹤0.01%	924
2019 Q1	$2.5M	Buy	+450,000	New	+$2.73M	﹤0.01%	941
2017 Q3	–	Sell	-104,566	Closed	-$1.72M	–	2145
2017 Q2	$1.72M	Buy	104,566 +36,300	+53%	+$562K	﹤0.01%	1013
2017 Q1	$979K	Sell	68,266 -165	-0.2%	-$2.45K	﹤0.01%	1186
2016 Q4	$946K	Buy	68,431 +12,531	+22%	+$201K	﹤0.01%	1171
2016 Q3	$1.01M	Buy	+55,900	New	+$900K	﹤0.01%	1146

Other funds holding LXRX

Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return

Fidelity Investments

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

Ulys LLC New York $25.4M AUM 201.03% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return

NEA Management Company Timonium, Maryland $1.76B AUM 223.33% 1-Year Est. Return

Pinnacle Associates New York $7.78B AUM 45.07% 1-Year Est. Return

Geode Capital Management

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return